Ignite Creation Date:
2025-12-24 @ 7:11 PM
Ignite Modification Date:
2025-12-29 @ 1:25 PM
Study NCT ID:
NCT05737303
Status:
RECRUITING
Last Update Posted:
2025-02-11
First Post:
2023-01-02
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Nab-paclitaxel Versus Sb-taxanes As First-Line Treatment in Advanced Ovarian Cancer
Sponsor:
Women's Hospital School Of Medicine Zhejiang University
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
IRB-20230058-R
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None